Effects of Adequate Iodine Supply on the Incidence of Iodine-Induced Thyroid Disorders in Slovenia

Thyroid

Volumn 27, Issue 4, 2017, Pages 558-566

  Bajuk, Vid ^a   Zaletel, Katja ^b   Pirnat, Edvard ^b   Hojker, Sergej ^a,b   Gaberšček, Simona ^a,b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

amiodarone; antithyroid drugs; excessive iodine intake; iodine supply; iodine containing contrast media; iodine induced hyperthyroidism; iodine induced hypothyroidism; perchlorate

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; IODINE; PERCHLORATE; THYROID ANTIBODY; THYROID HORMONE; THYROTROPIN; IODIZED SALT; TRACE ELEMENT;

ADOLESCENT; ADULT; AGED; CONFERENCE PAPER; DEMOGRAPHY; ECHOGRAPHY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; INTERNIST; IODINE INDUCED HYPERTHYROIDISM; IODINE INDUCED HYPOTHYROIDISM; IODINE SUPPLY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLOVENIA; SUBCLINICAL HYPERTHYROIDISM; THYROID SCINTISCANNING; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; CHEMICALLY INDUCED; MIDDLE AGED; NUTRITION POLICY; SALT INTAKE; SEVERITY OF ILLNESS INDEX; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITHYROID AGENTS; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; IODINE; MALE; MIDDLE AGED; NUTRITION POLICY; PERCHLORATES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLOVENIA; SODIUM CHLORIDE, DIETARY; TIME FACTORS; TRACE ELEMENTS; YOUNG ADULT;

EID: 85017159910     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2016.0186     Document Type: Conference Paper

References (36)

1. Zimmermann MB 2008 Iodine requirements and the risks and benefits of correcting iodine deficiency in populations. J Trace Elem Med Biol 22:81-92
2. Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, Pedersen IB, Carle A 2010 Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 24:13-27
3. Zaletel K, Gaberscek S, Pirnat E, Krhin B, Hojker S 2011 Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization. Croat Med J 52:615-621
4. Kotnik P, Sirca Campa A, Zupancic M, Stimec M, Smole K, Mis NF, Battelino T, Krzisnik C 2006 Goiter prevalence and urinary iodine concentration in Slovenian adolescents. Thyroid 16:769-773
5. Kaloumenou I, Alevizaki M, Ladopoulos C, Antoniou A, Duntas LH, Mastorakos G, Chiotis D, Mengreli C, Livadas S, Xekouki P, Dacou-Voutetakis C 2007 Thyroid volume and echostructure in schoolchildren living in an iodinereplete area: relation to age, pubertal stage, and body mass index. Thyroid 17:875-881
6. World Health Organization 2013 Assessment of iodine deficiency disorders and monitoring their elimination. Available at: www.who.int/nutrition/publications/micronutrients/iodine-deficiency/9789241595827/en/(accessed July 5, 2016)
7. Schaffhauser K, Hänscheid H, Rendl J, Grelle I, Reiners C 2005 Intrathyroidal iodine concentration after application of non-ionic contrast media with and without prophylactic application of perchlorate. Nuklearmedizin 44:143-148
8. Basaria S, Cooper DS 2005 Amiodarone and the thyroid. Am J Med 118:706-714
9. Eskes SA, Wiersinga WM 2009 Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 23:735-751
10. Albert SG, Alves LE, Rose EP 1987 Thyroid dysfunction during chronic amiodarone therapy. J Am Coll Cardiol 9: 175-183
11. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E 1996 Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 81:2930-2933
12. Bogazzi F, Bartalena L, Martino E 2010 Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95:2529-2535
13. Denef JF, Many MC, van den Hove MF 1996 Iodineinduced thyroid inhibition and cell necrosis: two consequences of the same free radical mediated mechanism Mol Cell Endocrinol 121:101-103
14. Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM; SAFE-T Investigators 2007 Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrilation. Am J Med 120:880-885
15. Goldman M, Landry D 1976 The effect of povidone-iodine on thyroid function in rats. Toxicol Appl Pharmacol 35: 341-346
16. Duntas LH 2011 Environmental factors and thyroid autoimmunity. Ann Endocrinol (Paris) 72:108-113
17. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin N, Macchia E, Haffajee C, et al. 1984 Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 101:28-34
18. Essebag V, Reynolds MR, Hadjis T, Lemery R, Olshansky B, Buxton AE, Josephson ME, Zimetbaum P 2007 Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med 167:1648-1653
19. Roten L, Rimoldi SF, Schwick N, Sakata T, Heimgartner C, Fuhrer J, Delacretaz E, Tanner H 2009 Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol 32:622-626
20. Laurberg P, Jørgensen T, Perrild H, Ovesen L, Knudsen N, Pedersen IB, Rasmussen LB, Carle A, Vejbjerg P 2006 The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol 155: 219-228
21. Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Carle A, Pedersen IB, Rasmussen LB, Ovesen L, Jørgensen T 2009 Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf) 71:440-445
22. Lind P, Kumnig G, Heinisch M, Igerc I, Mikosch P, Gallowitsch HJ, Kresnik E, Gomez I, Unterweger O, Aigner H 2002 Iodine supplementation in Austria: methods and results. Thyroid 12:903-907
23. Deckart H, Deckart E, Behringer F, Kühne H, Adam B, Apitz H, Eifler H, Grambow H, Hannemann R, Hans R, et al. 1990 [Incidence of autonomy and immune hyperthyroidism before and following preventive use of iodized salt in the Berlin-Brandenburg area] [Article in German]. Acta Med Austriaca 17:39-41
24. Baltisberger BL, Minder CE, Bürgi H 1995 Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 132:546-549
25. Gaberscek S, Bajuk V, Zaletel K, Pirnat E, Hojker S 2013 Beneficial effects of adequate iodine supply on characteristics of thyroid autonomy. Clin Endocrinol (Oxf) 79: 867-873
26. Kaloumenou I, Mastorakos G, Alevizaki M, Duntas LH, Mantzou E, Ladopoulos C, Antoniou A, Chiotis D, Papassotiriou I, Chrousos GP, Dacou-Voutetakis C 2008 Thyroid autoimmunity in schoolchildren in an area with long-standing iodine sufficiency: correlation with gender, pubertal stage, and maternal thyroid autoimmunity. Thyroid 18:747-754
27. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A 1999 The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84:561-566
28. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-899
29. Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y, Izumi Y 2009 Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid 19:937-944
30. Heydarian P, Ordookhani A, Azizi F 2007 Goiter rate, serum thyrotropin, thyroid autoantibodies and urinary iodine concentration in Tehranian adults before and after national salt iodization. J Endocrinol Invest 30:404-410
31. Reinhardt W, Luster M, Rudorff KH, Heckmann C, Petrasch S, Lederbogen S, Haase R, Saller B, Reiners C, Reinwein D, Mann K 1998 Effect of small doses of iodine in patients with Hashimoto's thyroiditis residing in an area of mild iodine deficiency. Eur J Endocrinol 139:23-28
32. Bürgi H 2010 Iodine excess. Best Pract Res Clin Endocrinol Metab 24:107-115
33. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-2533
34. Pedraza PE, Obregon MJ, Escobar-Morreale HF, del Rey FE, Escobar GM 2006 Mechanisms of adaptation to iodine deficiency in rats: thyroid status is tissue specific. Its relevance for man. Endocrinology 147:2098-2108
35. De Sandro V, Chevrier M, Boddaert A, Melcion C, Cordier A, Richert L 1991 Comparison of the effects of propylthiouracil, amiodarone, diphenylhydrantoin, phenobarbital and 3-methylcholanthrene on hepatic and renal metabolism and thyroid gland function in rats. Toxicol Appl Pharmacol 111:263-278
36. Völzke H, Caron P, Dahl L, de Castro JJ, Erlund I, Gabers cek S, Gunnarsdottir I, Hubalewska-Dydejczyk A, Ittermann T, Ivanova L, Karanfilski B, Khattak RM, Kusic Z, Laurberg P, Lazarus JH, Markou KB, Moreno-Reyes R, Nagy EV, Peeters RP, Prags V, Podoba J, Rayman MP, Rochau U, Siebert U, Smyth PP, Thuesen BH, Troen A, Vila L, Vitti P, Zamrazil V, Zimmermann MB 2016 Ensuring effective prevention of iodine deficiency disorders. Thyroid 26:189-196.